Author

Mario González-de la Parra

Biokinetics, S.A. de C.V. - Cited by 376 - bioequivalence - clinical trials - biostatistics - pharmaceutical chemistry - pharmaceutics

Biography

Dr. Mario Gonzalez de la Parra has received his PhD in Pharmacy from the University of Wisconsin-Madison during the period of 1981 to1986 Currently, he is working as Scientific Director in. Biokinetics, S.A. de C,V., Mexico City, Mexico. His research has included: bioequivalence-bioavailability-clinical trials; biostatistics and pharmaceutical chemistry. Based on this research and fellowship training he has received several certifications, such as: Biostatistics-Controlled Trials from the Institute for Statistics Education (satisitics.com).He is serving as an editorial member of Pragmatic and Observational Research. He has authored one patent and 45 research articles.
Title
Cited by
Year
Bioavailability of two sublingual formulations of ketorolac tromethamine 30 mg: a randomized, open-label, single-dose, two-period crossover comparison in healthy Mexican adult …
JF Galán-Herrera, JL Poo, JA Maya-Barrios, A de Lago, I Oliva, ...Clinical therapeutics 30 (9), 1667-1674, 2008200
24
2008
Application of the multivariate T2 control chart and the Mason–Tracy–Young decomposition procedure to the study of the consistency of impurity profiles of drug substances
M Gonzalez-de la Parra, P Rodriguez-LoaizaQuality Engineering 16 (1), 127-142, 2003200
21
2003
Bioavailability of two oral-suspension formulations of a single dose of nitazoxanide 500 mg: an open-label, randomized-sequence, two-period crossover, comparison in healthy …
JI Balderas-Acata, EP Ríos-Rogríguez Bueno, F Perez-Becerril, ...J Bioequiv Availab 3 (3), 043-7, 2011201
21
2011
Bioavailability of two oral formulations of azithromycin 500 mg: a randomized, open-label, two-period crossover comparison in healthy Mexican adult subjects
A Piñeyro-López, E Pineyro-Garza, O Torres-Alanís, R Reyes-Araiza, ...Clinical therapeutics 27 (10), 1607-1611, 2005200
18
2005
Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in …
JA Palma-Aguirre, JA Absalón-Reyes, G Novoa-Heckel, A de Lago, ...Clinical therapeutics 29 (6), 16-1152, 2007200
14
2007
Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers
JF Galan-Herrera, JL Poo, O Rosales-Sanchez, E Fuentes-Fuentes, ...Clinical therapeutics 31 (8), 1796-1803, 2009200
14
2009
Relative bioavailability of two oral formulations of piroxicam 20 mg: a single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Mexican adult …
JA Palma-Aguirre, M Lopez-Gamboa, L Carino, V Burke-Fraga, ...Clinical therapeutics 32 (2), 357-364, 2010201
14
2010
Naproxen, paracetamol and pamabrom versus paracetamol, pyrilamine and pamabrom in primary dysmenorrhea: a randomized, double-blind clinical trial
MI Ortiz, G Murguía-Cánovas, LC Vargas-López, R Silva, ...Medwave 16 (9), 6587, 201613201
13
2016
Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers
JL Poo, JF Galán, A Rosete, A de Lago, I Oliva, M González-de la Parra, ...Clinical therapeutics 30 (4), 693-699, 2008200
13
2008
Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period …
JA Palma-Aguirre, J Villalpando-Hernández, G Novoa-Heckel, I Oliva, ...Clinical therapeutics 31 (2), 399-410, 2009200
12
2009
Quantification of 4-aminopyridine in plasma by capillary electrophoresis with electrokinetic injection
S Namur, M González-de la Parra, G Castañeda-HernándezJournal of Chromatography B 878 (3-4), 290-294, 2010201
11
2010
Bioequivalence of two commercial preparations of trimethoprim/sulfamethoxazole: a randomized, single-dose, single-blind, crossover trial
RA Campero, RB Escudero, DDCV Alvarez, M Gonzalez-de la Parra, ...Clinical therapeutics 29 (2), 326-333, 2007200
10
2007
Using structural equation modeling (SEM) for the study of impurity profiles of drug substances
M Gonzalez-de la Parra, P Rodriguez-Loaiza, S NamurQuality Engineering 18 (2), 225-235, 2006200
9
2006
Development and validation of a densitometric HPTLC method for quantitative analysis of levofloxacin in human plasma
S Namur, L Cariño, M González-de la ParraJPC–Journal of Planar Chromatography–Modern TLC 21 (3), 20-212, 2008200
9
2008
Bioavailability of two coated-tablet formulations of a single dose of pantoprazole 40 mg: an open-label, randomized, two-period crossover, comparison in healthy Mexican adult …
JI Balderas-Acata, EP Ríos-Rogríguez Bueno, S del Castillo-García, ...J Bioequiv Availab 3, 077-081, 2011201
9
2011
Development and validation of a high-performance thin-layer chromatographic method, with densitometry, for quantitative analysis of ketorolac tromethamine in human plasma
E Lpez-Bojrquez, G Castaeda-Hernndez, M Parra, Gonzalez-de la Parra, ...Journal of AOAC International 91 (5), 1191-1195, 20020
8
2008
Application of analysis of means (ANOM) to nested designs for improving the visualization and understanding of the sources of variation of chemical and pharmaceutical processes
M Gonzalez-de la Parra, P Rodriguez-LoaizaQuality Engineering 15 (4), 663-60, 2003200
7
2003
Development and validation of a high-performance thin-layer chromatographic method, with densitometry, for quantitative analysis of tizoxanide (a metabolite of nitazoxanide) in …
S Namur, L Carino, M Gonzalez-de la ParraJPC-Journal of Planar Chromatography-Modern TLC 20 (5), 331-334, 20020
7
2007
Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: An open-label, randomized, two-period crossover comparison in healthy Mexican adult …
A Piñeyro-López, E Pineyro-Garza, O Torres-Alanís, R Reyes-Araiza, ...Clinical therapeutics 28 (1), 110-115, 20020
6
2006
Studying unidentified impurities in drug substances by the application of multivariate (principal component and cluster) analysis
M Gonzalez-de la Parra, P Rodriguez-Loaiza, S NamurQuality Engineering 1 (3), 475-485, 2004200
6
2004

Referred From: https://scholar.google.com/citations?user=LTwkgDAAAAAJ&hl=en&oi=sra

Cited by
Citations 376
h-index 12
i10-index 17
Recommended Journals
Open Access Journals